Improving Radiotherapy Responses in Head and Neck Cancer With Galectin-1

1 Views
administrator
administrator
07/06/23

Dhanya K. Nambiar, PhD, Stanford University, discusses a study exploring galectin-1 in combination with radiation and immune checkpoint therapy in head and neck cancers.

Show more

0 Comments Sort By

No comments found

Facebook Comments

Up next